Notebook

The past several weeks have been busy ones for the genomics crowd. Genome scientists from around the world can now lay claim to having determined the entire genetic blueprint for five free-living species, including brewer's yeast, the most complex creature tackled thus far. Late last month, scientists from a European-led consortium of more than 70 international labs released the yeast sequence. The genome of Saccharomyces cerevisiae is the first organism with a distinct nucleus, or eukaryote, t

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The past several weeks have been busy ones for the genomics crowd. Genome scientists from around the world can now lay claim to having determined the entire genetic blueprint for five free-living species, including brewer's yeast, the most complex creature tackled thus far. Late last month, scientists from a European-led consortium of more than 70 international labs released the yeast sequence. The genome of Saccharomyces cerevisiae is the first organism with a distinct nucleus, or eukaryote, to be fully sequenced. About one-third of yeast's 6,000 genes are similar to those in humans. Some of the common genes govern such critical processes as DNA repair and protein synthesis. The researchers will also be able to celebrate their achievements with an appropriate libation: Britain's first genetically engineered beer, which was released earlier this year. The brew, Nutfield Light, was concocted by yeast researchers at the Brewing Research Foundation in Red Hill, Surrey, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies